The amount of crap this company spins. My favourite is the separation of "onerous contract" costs. You entered it. Its operational. You can't exclude your **ck-ups from financial results .... Same with excluding interest costs. You borrowed money to run your business. Interest is payable. Count it.
Anyway, ignoring all the crap and ins and outs of tax balancing payments etc ... on first analysis I have:
- Debt increased by $8m
- $4m spent on Share buy back (stop laughing ...)
- Net tax refund $11m
- $67m spent on purchase of ARN stake.
So cash generated for the half (ie true return to shareholders) was 67-11+4-8 = $52m. This is about 3.2cps. If this is annualised, we have 6.4cps. Can justify a multiple of 8 x cash generated, so this gives 51cps.
Of course you then need to discount by about 50% to account for the fact that Stokes and Warburton keep all the money for themselves.
Looks like the market is pretty much spot on.
- Forums
- ASX - By Stock
- SWM
- Ann: Presentation of Half Year Results
SWM
seven west media limited
Add to My Watchlist
3.45%
!
15.0¢

Ann: Presentation of Half Year Results, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.0¢ |
Change
0.005(3.45%) |
Mkt cap ! $230.8M |
Open | High | Low | Value | Volume |
14.0¢ | 15.0¢ | 14.0¢ | $263.2K | 1.793M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 85427 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 641436 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 85427 | 0.145 |
15 | 1172091 | 0.140 |
13 | 399189 | 0.135 |
10 | 343803 | 0.130 |
5 | 177900 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 641436 | 15 |
0.160 | 336037 | 8 |
0.165 | 632629 | 7 |
0.170 | 211677 | 12 |
0.175 | 496403 | 7 |
Last trade - 16.17pm 26/06/2025 (20 minute delay) ? |
Featured News
SWM (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online